NO995500D0 - Anvendelse av en farmasöytisk sammensetning til behandling av/eller forhindring av ischemi - Google Patents

Anvendelse av en farmasöytisk sammensetning til behandling av/eller forhindring av ischemi

Info

Publication number
NO995500D0
NO995500D0 NO995500A NO995500A NO995500D0 NO 995500 D0 NO995500 D0 NO 995500D0 NO 995500 A NO995500 A NO 995500A NO 995500 A NO995500 A NO 995500A NO 995500 D0 NO995500 D0 NO 995500D0
Authority
NO
Norway
Prior art keywords
ischemia
prevention
treatment
pharmaceutical composition
pharmaceutical
Prior art date
Application number
NO995500A
Other languages
English (en)
Other versions
NO995500L (no
Inventor
Carine Michiels
Original Assignee
Remacle Jose
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Remacle Jose filed Critical Remacle Jose
Publication of NO995500D0 publication Critical patent/NO995500D0/no
Publication of NO995500L publication Critical patent/NO995500L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A61K31/175—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine having the group, >N—C(O)—N=N— or, e.g. carbonohydrazides, carbazones, semicarbazides, semicarbazones; Thioanalogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO995500A 1997-05-13 1999-11-10 Anvendelse av en farmasøytisk sammensetning til behandling av/eller forhindring av ischemi NO995500L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE9700415A BE1011151A3 (fr) 1997-05-13 1997-05-13 Utilisation d'une composition pharmaceutique dans le traitement et/ou la prevention de l'ischemie.
PCT/BE1998/000067 WO1998051291A1 (fr) 1997-05-13 1998-05-12 Utilisation d'une composition pharmaceutique dans le traitement et/ou la prevention de l'ischemie

Publications (2)

Publication Number Publication Date
NO995500D0 true NO995500D0 (no) 1999-11-10
NO995500L NO995500L (no) 1999-11-10

Family

ID=3890512

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995500A NO995500L (no) 1997-05-13 1999-11-10 Anvendelse av en farmasøytisk sammensetning til behandling av/eller forhindring av ischemi

Country Status (7)

Country Link
EP (1) EP0981339A1 (no)
JP (1) JP2001526658A (no)
AU (1) AU7327298A (no)
BE (1) BE1011151A3 (no)
CA (1) CA2287363A1 (no)
NO (1) NO995500L (no)
WO (1) WO1998051291A1 (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792203B1 (fr) * 1999-04-19 2003-05-16 Mu Laboratoire Nouvelle composition a base d'extraits vegetaux naturels, et son utilisation, notamment dans les domaines pharmaceutiques ou cosmetiques
FR2796552A1 (fr) * 1999-07-21 2001-01-26 Centre Nat Rech Scient Nouvelle utilisation de derives de la beta-naphtoquinone et de leurs sels pour la fabrication de medicaments exercant un effet inhibiteur sur la liberation de glutamate dans le cerveau
FR2802425B1 (fr) * 1999-12-21 2003-09-26 Oreal Utilisation d'un extrait d'au moins un vegetal de la famille des ericaceae comme agent anti-glycation
EP1127572A3 (en) * 2000-02-25 2003-05-02 Basf Aktiengesellschaft Use of flavones for treating cycloxygenase-2 mediated diseases
FR2814950B1 (fr) * 2000-10-05 2003-08-08 Oreal Utilisation d'au moins un extrait d'au moins un vegetal de la famille des ericaceae, dans des compositions destinees a traiter les signes cutanes du vieillissement
DE10122714A1 (de) * 2001-05-10 2002-11-21 Brench Ag Verwendung von Rutinen und Aescinen zur Behandlung okulärer Durchblutungsstörungen
DE10122715A1 (de) * 2001-05-10 2002-11-21 Brench Ag Verwendung von Rutinen und Aescinen zur Behandlung aurikulärer Durchblutungsstörungen
EP1382326A1 (de) * 2002-07-17 2004-01-21 Cognis France S.A. Verfahren zum Schutz der Haut gegen die Alterung
EP1382327A1 (de) * 2002-07-17 2004-01-21 Cognis France S.A. Verfahren zum Schutz der Haut gegen die Alterung
FR2844716B1 (fr) * 2002-09-23 2008-11-21 Marcel Jacques Chicouri Nouvelles compositions pharmaceutiques destinees notamment a l'hygiene des pieds des diabetiques
JP4562365B2 (ja) * 2003-09-19 2010-10-13 株式会社ノエビア 健康増進用組成物
EP1550450A1 (en) * 2003-12-29 2005-07-06 Boehringer Ingelheim International GmbH Composition comprising an aqueous extract of red vine leaves and a blood circulating-improving agent for the treatment of chronic venous insufficiencies
EP1588705A1 (en) * 2004-04-21 2005-10-26 INTE:LIGAND Software-Entwicklungs und Consulting GmbH Use of coumarin derivatives
EP1607006A1 (en) * 2004-06-18 2005-12-21 Unilever N.V. Functional berry composition
CA2614110A1 (en) * 2005-07-01 2007-01-11 The Johns Hopkins University Compositions and methods for the treatment or prevention of disorders relating to oxidative stress
FR2904222A1 (fr) 2006-07-27 2008-02-01 Sod Conseils Rech Applic Utilisation d4extraits de ginkgo biloba pour le traitement de maladies mitochondriales
KR100880876B1 (ko) * 2007-04-11 2009-01-30 경상대학교산학협력단 검정콩 껍질로부터 추출한 안토시아닌을 함유하는 피판이나조직의 허혈-재관류 손상의 예방 또는 치료용 의약 조성물
DE102007033067A1 (de) * 2007-07-13 2009-01-15 Institut für Umweltmedizinische Forschung gGmbH Zubereitungen zur Verbesserung des Schutzes menschlicher Zellen, insbesondere Zellen der menschlichen Haut vor schädigenden Einflüssen durch oxidative Noxen und UV-Bestrahlung
EP2014276A1 (en) 2007-06-20 2009-01-14 Cognis IP Management GmbH Cosmetic compositions comprising sclareolide and hesperidin methyl chalcone
MD3987C2 (ro) * 2009-09-03 2010-07-31 Георге АНГЕЛИЧ Utilizare a Diosminei pentru tratamentul cirozei hepatice avansate asociate cu insuficienţă cardiacă
MD3986C2 (ro) * 2009-09-23 2010-07-31 Георге АНГЕЛИЧ Utilizare a Diosminei pentru tratamentul gastropatiilor portale în ciroza hepatică
MD4232C1 (ro) * 2012-11-08 2014-01-31 Георге АНГЕЛИЧ Remediu medicamentos pe bază de troxerutin şi carbazocrom pentru tratamentul cirozei hepatice avansate asociate cu insuficienţă cardiacă
MD4231C1 (ro) * 2012-11-08 2014-01-31 Георге АНГЕЛИЧ Remediu medicamentos pe bază de troxerutin şi carbazocrom pentru tratamentul gastropatiilor portale în ciroza hepatică
CN110585222B (zh) * 2019-10-12 2023-05-09 西南医科大学 七叶皂苷类化合物在制备药物中的应用
IT202000010924A1 (it) * 2020-05-13 2021-11-13 Neilos S R L “composizione per la prevenzione e il trattamento di patologie dell’apparato circolatorio e dei sintomi correlati”
CN112138015B (zh) * 2020-10-22 2022-08-05 合肥博思科创医药科技有限公司 三苄糖苷在治疗微循环障碍引起的皮肤疾病中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3623255A1 (de) * 1986-07-10 1988-01-21 Oxo Chemie Gmbh Pharmazeutisches mittel zur verhinderung oxidativer blutgefaess-schaedigungen
DE3808835A1 (de) * 1987-03-27 1988-10-06 Sandoz Ag Arzneimittel enthaltend eine mischung aus dihydroergotamin, etilefrin und troxerutin
FR2707495B1 (fr) * 1993-07-02 1995-09-01 Roussel Uclaf Nouvelle utilisation de dérivés de la béta-naphtoquinone ainsi que de leurs sels.
FR2726469B1 (fr) * 1994-11-08 1996-12-13 Adir Composition pharmaceutique pour l'administration orale de flavonoides

Also Published As

Publication number Publication date
WO1998051291A1 (fr) 1998-11-19
EP0981339A1 (fr) 2000-03-01
CA2287363A1 (en) 1998-11-19
BE1011151A3 (fr) 1999-05-04
JP2001526658A (ja) 2001-12-18
AU7327298A (en) 1998-12-08
NO995500L (no) 1999-11-10

Similar Documents

Publication Publication Date Title
NO995500L (no) Anvendelse av en farmasøytisk sammensetning til behandling av/eller forhindring av ischemi
NO20006630D0 (no) Farmasöytisk sammensetning for behandlingen av diabetes
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
IS2184B (is) Lyfjaform með áfangalosun til inntöku um munn
HUP0003851A3 (en) Pharmaceutical composition for the treatment or prevention of glomerulopathy
DK0797991T3 (da) Lægemiddelformulering med forhalet frigivelse
NO990594D0 (no) Farmas°ytisk aerosolsammensetning
FI944832A (fi) Farmaseuttinen koostumus
ID25543A (id) Alpha-aril-n-alkinitron dan komposisi farmasi yang mengandungnya
FI973475A (fi) Koostumus ja sitä sisältävä tuote
TR199800436A3 (tr) Primidin türevlerinin kanserin önlenmesi için kullanilmasi.
AU4966497A (en) Novel acylamino-substituted acylanilide derivatives or pharmaceutical composition comprising the same
BR9701673A (pt) Disposição para a aplicação de um líquido medicinal
NO985539D0 (no) Farmas°ytiske blandinger
ID25535A (id) Komposisi batangan yang terdiri dari tetesan-tetesan pelunak yang terperangkap terdispersi padanya
DE69812708D1 (de) Neue arzneimittel enthaltend uridintriphosphat
ITMI950855A0 (it) Procedimento per la protezione delle superfici lapidee o di rivestimento
BR9806083A (pt) Composi-Æo farmac-utica para o tratamento da hapattite c
ID29294A (id) Komposisi farmasi
NO934832D0 (no) Farmasoeytisk sammensetning for forhindring eller behandling av ar terioscherose
ID18698A (id) Komposisi farmasi
ZA989238B (en) Benzimidazole compounds pharmaceutical compositions containing the compounds and their use
NO983784L (no) Fremgangsmåter for fremstilling av bifenyl-isoksasolsulfonamider
NO993549L (no) Imino-aza-antracyklinonderivater til behandling av amyloidosis
AP9700928A0 (en) Pharmaceutical compositions for the prevention or treatment of retrovirus infections

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application